Invention Grant
- Patent Title: Organic compounds
- Patent Title (中): 有机化合物
-
Application No.: US12280674Application Date: 2007-02-21
-
Publication No.: US08420787B2Publication Date: 2013-04-16
- Inventor: Michael Bardroff , Matthew Edwards , Mehmet Kemal Tur , Olaf Ratsch
- Applicant: Michael Bardroff , Matthew Edwards , Mehmet Kemal Tur , Olaf Ratsch
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Frank Wu
- Priority: GB0603683.4 20060223
- International Application: PCT/EP2007/001506 WO 20070221
- International Announcement: WO2007/096149 WO 20070830
- Main IPC: C12P21/08
- IPC: C12P21/08
Abstract:
The present invention relates to human thymic stromal lymphopoietin (hTSLP) antibodies and especially those which neutralize hTSLP activity. It further relates to methods for using anti-hTSLP antibody molecules in diagnosis or treatment of hTSLP related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease, and Hodgkin's lymphoma.
Public/Granted literature
- US20090186022A1 Organic Compounds Public/Granted day:2009-07-23
Information query
